Return to search

Collegium Pharmaceuticals

Collegium Pharmaceuticals Inc., a Cumberland, R.I.-based developer of late-stage drugs that add market value and clinical benefit to existing products, has raised $5.5 million in Series C funding, according to a regulatory filing. Backers include Boston Millennia Partners and Westfield Capital Management. www.collegiumpharma.com